Cargando…
Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
BACKGROUND: Oxaliplatin, an effective antineoplastic agent againstgastrointestinal tumors, can cause severe peripheral neurotoxicity, which seriously limits its clinical application. To date, there are no effective treatments for this complication. Ganglioside-monosialic acid (GM1) has been shown to...
Autores principales: | Zhu, Yanyun, Yang, Junlan, Jiao, Shunchang, Ji, Tiefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575266/ https://www.ncbi.nlm.nih.gov/pubmed/23351188 http://dx.doi.org/10.1186/1477-7819-11-19 |
Ejemplares similares
-
Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis
por: Wu, Shaoyong, et al.
Publicado: (2021) -
Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial
por: Xu, Junnan, et al.
Publicado: (2020) -
Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy
por: Zhu, Yanyun, et al.
Publicado: (2013) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022)